Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Launch Two Acquisition Units | LPBBU | Mar 14, 2025 | 10.16 | +0.10 |
Laureate Education | LAUR | Mar 14, 2025 | 18.89 | +2.16 |
LAVA Therapeutics | LVTX | Mar 14, 2025 | 1.30 | -2.26 |
Lavoro | LVRO | Mar 14, 2025 | 3.89 | -1.77 |
Lazard A | LAZ | Mar 14, 2025 | 44.93 | 0.00 |
Lazard Global Total Return and Income Fund | LGI | Mar 14, 2025 | 15.57 | +1.24 |
Lazydays | GORV | Mar 14, 2025 | 0.61 | -5.59 |
LCI Industries | LCII | Mar 14, 2025 | 89.79 | +2.58 |
LCNB | LCNB | Mar 14, 2025 | 14.87 | +2.41 |
Lead Real Estate ADR | LRE | Mar 14, 2025 | 1.15 | +4.55 |
Leap Therapeutics | LPTX | Mar 14, 2025 | 0.40 | +2.33 |
Lear | LEA | Mar 14, 2025 | 94.71 | +1.29 |
LeddarTech | LDTC | Mar 14, 2025 | 0.50 | +2.18 |
Lee Enterprises | LEE | Mar 14, 2025 | 8.40 | 0.00 |
Legacy Housing | LEGH | Mar 14, 2025 | 25.96 | +2.16 |
LegalZoom.com | LZ | Mar 14, 2025 | 9.30 | +3.56 |
Legato Merger III | LEGT | Mar 14, 2025 | 10.44 | 0.00 |
Legend Biotech ADR | LEGN | Mar 14, 2025 | 37.20 | -2.23 |
Legg Mason Low Volatility High Dividend ETF | LVHD | Mar 14, 2025 | 40.02 | +1.32 |
Leggett & Platt | LEG | Mar 14, 2025 | 8.11 | +1.50 |
Leidos | LDOS | Mar 14, 2025 | 134.55 | +1.27 |
Leishen Energy Holding Co | LSE | Mar 14, 2025 | 5.49 | 0.00 |
LeMaitre Vascular | LMAT | Mar 14, 2025 | 81.91 | +3.92 |
Lemonade | LMND | Mar 14, 2025 | 34.97 | +7.27 |
LendingClub | LC | Mar 14, 2025 | 10.87 | +4.42 |
LendingTree | TREE | Mar 14, 2025 | 49.26 | +5.84 |
Lendway | LDWY | Mar 14, 2025 | 3.76 | -3.28 |
Lennar A | LEN | Mar 14, 2025 | 118.10 | +1.52 |
Lennar B | LEN-B | Mar 14, 2025 | 111.79 | +1.19 |
Lennox International | LII | Mar 14, 2025 | 574.92 | +2.94 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.